Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,735 | 9 | 94.0% |
| Food and Beverage | $3,084 | 172 | 4.8% |
| Travel and Lodging | $781.59 | 2 | 1.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theravance Biopharma Inc. | $60,735 | 9 | $0 (2017) |
| Genentech, Inc. | $921.89 | 3 | $0 (2018) |
| ABBVIE INC. | $595.28 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $449.25 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $328.54 | 22 | $0 (2024) |
| PFIZER INC. | $237.89 | 15 | $0 (2021) |
| Esperion Therapeutics, Inc. | $133.40 | 6 | $0 (2021) |
| Astellas Pharma US Inc | $122.91 | 8 | $0 (2024) |
| Allergan, Inc. | $121.05 | 8 | $0 (2020) |
| Inari Medical, Inc. | $67.47 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.14 | 5 | Astellas Pharma US Inc ($34.82) |
| 2023 | $568.41 | 29 | GlaxoSmithKline, LLC. ($120.67) |
| 2022 | $538.24 | 34 | ABBVIE INC. ($166.17) |
| 2021 | $936.39 | 51 | AbbVie Inc. ($327.52) |
| 2020 | $270.64 | 16 | Allergan, Inc. ($94.45) |
| 2019 | $314.16 | 22 | PFIZER INC. ($100.97) |
| 2018 | $1,136 | 16 | Genentech, Inc. ($921.89) |
| 2017 | $60,746 | 10 | Theravance Biopharma Inc. ($60,735) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Biological | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Biological | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: DEVICE | ||||||
| 08/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Respiratory | ||||||
| 08/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Biological | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 06/12/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $67.47 | General |
| Category: VTE | ||||||
| 06/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 0128 TD-4208 | Theravance Biopharma Inc. | $60,735 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,457 | 1,787 | $120,396 | $38,253 |
| 2022 | 20 | 1,987 | 2,790 | $179,920 | $55,415 |
| 2021 | 24 | 2,157 | 2,785 | $203,575 | $67,999 |
| 2020 | 11 | 671 | 930 | $124,599 | $35,427 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 111 | $25,763 | $8,938 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 100 | $15,600 | $6,319 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $8,362 | $4,300 | 51.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 178 | 216 | $9,936 | $3,555 | 35.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 178 | 221 | $11,271 | $2,876 | 25.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 189 | 241 | $13,255 | $2,485 | 18.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 174 | 225 | $10,350 | $2,125 | 20.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 210 | 279 | $5,022 | $2,117 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 15 | $5,370 | $1,392 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 105 | 126 | $1,386 | $1,058 | 76.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 53 | 57 | $3,819 | $1,027 | 26.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 17 | 17 | $3,043 | $493.17 | 16.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 12 | 12 | $1,536 | $485.40 | 31.6% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 17 | 17 | $1,615 | $282.20 | 17.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 14 | 14 | $616.00 | $264.88 | 43.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 17 | 17 | $1,411 | $150.28 | 10.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 23 | 24 | $768.00 | $135.84 | 17.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 36 | 37 | $481.00 | $126.17 | 26.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 23 | 24 | $792.00 | $121.92 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 152 | $35,264 | $11,724 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 133 | $20,748 | $8,646 | 41.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 246 | 352 | $16,192 | $5,838 | 36.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 253 | 378 | $19,278 | $4,984 | 25.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $8,991 | $4,769 | 53.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 268 | 425 | $23,375 | $4,431 | 19.0% |
About Dr. Tim Shepherd, M.D
Dr. Tim Shepherd, M.D is a Family Medicine healthcare provider based in Lewisville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760488027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tim Shepherd, M.D has received a total of $64,601 in payments from pharmaceutical and medical device companies, with $91.14 received in 2024. These payments were reported across 183 transactions from 37 companies. The most common payment nature is "" ($60,735).
As a Medicare-enrolled provider, Shepherd has provided services to 6,272 Medicare beneficiaries, totaling 8,292 services with total Medicare billing of $197,093. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lewisville, TX
- Active Since 06/22/2005
- Last Updated 08/03/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760488027
Products in Payments
- Non-Covered Product (Drug) $921.89
- VRAYLAR (Drug) $392.20
- TRELEGY ELLIPTA (Drug) $361.16
- UBRELVY (Drug) $235.08
- FARXIGA (Drug) $179.35
- BREZTRI (Drug) $134.25
- NEXLETOL (Drug) $133.40
- CHANTIX (Drug) $115.66
- NURTEC ODT (Drug) $108.68
- AREXVY (Drug) $70.69
- FLOWTRIEVER CATHETER, S (Device) $67.47
- LONHALA MAGNAIR (Drug) $62.52
- LYRICA (Drug) $61.63
- MYRBETRIQ (Drug) $56.41
- QULIPTA (Drug) $56.05
- Veozah (Drug) $55.21
- XIFAXAN (Drug) $50.66
- INTELLIS ADAPTIVESTIM (Device) $48.05
- Vascepa (Drug) $46.99
- Kerendia (Drug) $46.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lewisville
Dr. Leigh Summer, M.d, M.D
Family Medicine — Payments: $4,967
Hardik Shah, M.d, M.D
Family Medicine — Payments: $4,605
Sheldon Cho, Md, MD
Family Medicine — Payments: $4,514
William Williams, Md, MD
Family Medicine — Payments: $4,100
Archana Chandra, Md, MD
Family Medicine — Payments: $3,527
Terry Hess, Md, MD
Family Medicine — Payments: $3,206